Share This Article:

Cutaneous B cell lymphoma presenting as a soft tissue swelling

Abstract Full-Text HTML XML Download Download as PDF (Size:769KB) PP. 143-146
DOI: 10.4236/crcm.2013.22039    3,820 Downloads   5,389 Views  

ABSTRACT

Cutaneous lymphomas are classified as B cell and T cell lymphomas which are seen very rarely. They present as papules or nodules in the absence of any extracutaneous involvement. We present a patient who had a diffuse cutaneous B cell lymphoma and review literature of this uncommon tumour.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Rekha, A. , Vivekanandan, S. and Ravi, A. (2013) Cutaneous B cell lymphoma presenting as a soft tissue swelling. Case Reports in Clinical Medicine, 2, 143-146. doi: 10.4236/crcm.2013.22039.

References

[1] Odom, R.B., James, W.D. and Berger, T.G. (2000) Cutaneous lymphoid hyperplasia, cutaneous T-cell lymphoma, other malignant lymphomas, and allied diseases. In: Andrews’ Diseases of the Skin, Clinical Dermatology. 9th Edition, W.B. Saunders Company, Philadelphia, 918-942.
[2] Fink-Puches, R., Zenahlik, P., Bäck, B., Smolle, J., Kerl, H. and Cerroni, L. (2002) Primary cutaneous lymphomas: Applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients. Blood, 99, 800-805. doi:10.1182/blood.V99.3.800
[3] Willemze, R., Kerl, H., Sterry, W., et al. (1997) EORTC classification for primary cutaneoulymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood, 90, 354-371.
[4] Goodlad, J.R., Krajewski, A.S., Batstone, P.J., et al. (2003) Primary cutaneous diffuse large B-cell lymphoma: Prognostic significance and clinicopathologic subtypes. American Journal of Surgical Pathology, 27, 1538-1545. doi:10.1097/00000478-200312000-00006
[5] Nagore, E., Ledesma, E., Collado, C., Oliver, V., Pérez-Pérez, A. and Aliaga A. (2000) Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas. British Journal of Dermatology, 143, 320-323. doi:10.1046/j.1365-2133.2000.03657.x
[6] Ichiyama, S., Yokote, T., Iwaki, K., Miyoshi, T., Takubo, T., Tsuji, M. and Hanafusa, T. (2011) Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type. British Journal of Haematology, 155, 514-516. doi:10.1111/j.1365-2141.2011.08702.x
[7] Garbe, C., Stein, H., Dienemann, D. and Orfanos, C.E. (1991) Borrelia burgdorferi-associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization offour cases. Journal of the American Academy of Dermatology, 24, 584-590. doi:10.1016/0190-9622(91)70088-J
[8] Cerroni, L., Volkenandt, M., Rieger, E., Soyer, H.P. and Kerl, H. (1994) bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. Journal of Investigative Dermatology, 102, 231-235. doi:10.1111/1523-1747.ep12371768
[9] Grange, F., Bekkenk, M.W., Wechsler, J., et al. (2001) Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study. Journal of Clinical Oncology, 19, 3602-3610.
[10] Zinzani, P.L., Quaglino, P., Pimpinelli, N., et al. (2006) Prognostic factors in primary cutaneous B-cell lymphoma: The Italian study group for cutaneous lymphomas. Journal of Clinical Oncology, 24, 1376-1382. doi:10.1200/JCO.2005.03.6285
[11] Zenahlik, P., Fink-Puches, R., Kapp, K.S., Kerl, H. and Cerroni, L. (2000) Therapy of primary cutaneous B-cell lymphomas. Hautarzt, 51, 19-24. doi:10.1007/s001050050005
[12] Dreno, B. (2006) Standard and new treatments in cutaneous B cell lymphoma. Journal of Cutaneous Pathology, 33, 47-51.
[13] Heinzerling, L.M., Urbanek, M., Funk, J.O., et al. (2000) Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer, 89, 1835-1844. doi:10.1002/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H
[14] Peñate, Y., Hernández-Machín, B., Pérez-Méndez, L.I., Santiago, F., Rosales, B., Servitje, O., Estrach, T., Fernández-Guarino, M., Calzado, L., Acebo, E., Gallardo, F., Salar, A., Izu, R., Ortiz-Romero, P.L., Pujol, R.M. and Fernández-de-Misa, R. (2012) Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma. British Journal of Dermatology, 167, 174-179. doi:10.1111/j.1365-2133.2012.10902.x
[15] Pashtan, I., Mauch, P.M., Chen, Y.H., Dorfman, D.M., Silver, B. and Ng, A.K. (2012) Radiotherapy in the management of localized primary cutaneous B-cell lymphoma. Leukemia & Lymphoma, 54, 726-730.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.